Biography

Dr. Winson Y. Cheung, MD, MPH, is a medical oncologist and real-world data scientist with over 15 years of cancer research experience. He is currently a Full Professor in the Departments of Oncology, Medicine, and Community Health Sciences at the University of Calgary.

 

Dr. Cheung received his medical degree at the University of British Columbia, medical oncology subspecialty training at the University of Toronto and subsequently obtained a Masters of Public Health degree at Harvard University. He specializes in the management of gastrointestinal malignancies. He is the recipient of numerous accolades, including the National Cancer Institute of Canada Dorothy Lamont Award, the Canadian Cancer Trials Group Dr Ralph Meyer Award, the Novartis Oncology Canadian Investigator Mentor Award, the Multinational Association of Supportive Care in Cancer Investigator Award, and several merit awards from the American Society of Clinical Oncology. He has secured over 20 million dollars in grant funding and published more than 300 peer-reviewed scientific manuscripts.

 

Dr. Cheung’s main research interest is health outcomes research and real world evidence (RWE) generation across all cancer types, including solid tumors and hematologic malignancies. His track record consists of over 150 invited presentations and over 300 peer-reviewed scientific manuscripts in the RWE space.

Area of Focus

Real world evidence; real world data; patient support programs; quality of life indicators, outcomes research; synthetic data; advanced analytics

Summary of Research

Dr. Winson Cheung is the Principal Director of Oncology Outcomes (O2).

The Oncology Outcomes (O2) program is focused on real-world evidence (RWE) generation in oncology. The team conducts rigorous research to accelerate clinical practice and policy impact with the end goal of improving patient outcomes. Novel approaches are developed and used to understand gaps and needs within unique cancer groups. The group also develops innovative tools to help with reducing uncertainty in decision making.

Area Of Focus

Real world evidence; real world data; patient support programs; quality of life indicators, outcomes research; synthetic data; advanced analytics

Summary Of Research

Dr. Winson Cheung is the Principal Director of Oncology Outcomes (O2).

The Oncology Outcomes (O2) program is focused on real-world evidence (RWE) generation in oncology. The team conducts rigorous research to accelerate clinical practice and policy impact with the end goal of improving patient outcomes. Novel approaches are developed and used to understand gaps and needs within unique cancer groups. The group also develops innovative tools to help with reducing uncertainty in decision making.